T1	Date 3 15	January 2009
E1	Date:T1 
T2	Age 19 30	57-year-old
T3	Sex 31 36	woman
T4	Clinical_event 48 57	presented
E2	Clinical_event:T4 
T5	Sign_symptom 69 88	shortness of breath
E3	Sign_symptom:T5 
T6	Duration 100 107	1-month
E4	Duration:T6 
T7	Sign_symptom 131 150	shortness of breath
E5	Sign_symptom:T7 
T8	Detailed_description 119 130	progressive
T9	Diagnostic_procedure 177 194	exercise capacity
E6	Diagnostic_procedure:T9 
T10	Lab_value 157 173	gradual decrease
R1	MODIFY Arg1:T10 Arg2:E6	
T11	Sign_symptom 213 220	dyspnea
E7	Sign_symptom:T11 
T12	Severity 208 212	mild
R2	MODIFY Arg1:T12 Arg2:E7	
T13	Sign_symptom 238 257	additional symptoms
E8	Sign_symptom:T13 
A1	POLARITY E8 NEG
R3	MODIFY Arg1:T8 Arg2:E5	
T14	Date 262 268	age 40
E9	Date:T14 
T15	Clinical_event 283 292	diagnosed
E10	Clinical_event:T15 
T19	Disease_disorder 329 342	breast cancer
E11	Disease_disorder:T19 
T20	Detailed_description 318 328	left-sided
R4	MODIFY Arg1:T20 Arg2:E11	
T21	Lab_value 311 316	T1bN1
R5	MODIFY Arg1:T21 Arg2:E11	
T22	Lab_value 300 309	stage IIA
R6	MODIFY Arg1:T22 Arg2:E11	
T23	History 300 342	stage IIA, T1bN1, left-sided breast cancer
T24	Therapeutic_procedure 377 387	lumpectomy
E12	Therapeutic_procedure:T24 
T25	Therapeutic_procedure 401 416	node dissection
E13	Therapeutic_procedure:T25 
T26	Biological_structure 392 400	axillary
R7	MODIFY Arg1:T26 Arg2:E13	
T27	Medication 457 468	DOX therapy
E14	Medication:T27 
T28	Dosage 470 478	75 mg/m2
R8	MODIFY Arg1:T28 Arg2:E14	
T29	Dosage 445 453	4 cycles
R9	MODIFY Arg1:T29 Arg2:E14	
T30	Dosage 493 501	8 cycles
T31	Medication 505 521	cyclophosphamide
E15	Medication:T31 
T32	Medication 523 535	methotrexate
E16	Medication:T32 
T33	Medication 541 555	5-fluorouracil
E17	Medication:T33 
T34	Diagnostic_procedure 557 585	Multigated acquisition scans
E18	Diagnostic_procedure:T34 
T35	Medication 603 615	chemotherapy
E19	Medication:T35 
T36	Diagnostic_procedure 630 646	cardiac function
E20	Diagnostic_procedure:T36 
T37	Lab_value 623 629	normal
R10	MODIFY Arg1:T37 Arg2:E20	
T38	Medication 654 666	chemotherapy
E21	Medication:T38 
T39	Therapeutic_procedure 700 709	radiation
E22	Therapeutic_procedure:T39 
T40	Biological_structure 682 699	left whole-breast
R11	MODIFY Arg1:T40 Arg2:E22	
T41	Detailed_description 718 732	axillary boost
R12	MODIFY Arg1:T41 Arg2:E22	
T42	Sign_symptom 746 751	tumor
E23	Sign_symptom:T42 
T43	Detailed_description 761 787	estrogen receptor-positive
R13	MODIFY Arg1:T43 Arg2:E23	
T44	Medication 838 859	anti-estrogen therapy
E24	Medication:T44 
T45	Medication 870 879	tamoxifen
E25	Medication:T45 
T16	Duration 884 891	5 years
E26	Duration:T16 
T17	Medication 934 943	letrozole
E27	Medication:T17 
T18	Duration 952 966	17 years after
E28	Duration:T18 
T46	Sign_symptom 994 1000	active
E29	Sign_symptom:T46 
T47	Diagnostic_procedure 1024 1030	health
E30	Diagnostic_procedure:T47 
T48	Lab_value 1008 1023	relatively good
R14	MODIFY Arg1:T48 Arg2:E30	
T49	Sign_symptom 1090 1101	tachycardia
E31	Sign_symptom:T49 
T50	Sign_symptom 1103 1112	tachypnea
E32	Sign_symptom:T50 
T51	Sign_symptom 1118 1130	hypertension
E33	Sign_symptom:T51 
T52	Sign_symptom 1162 1172	distention
E34	Sign_symptom:T52 
T53	Biological_structure 1147 1161	jugular venous
T54	Sign_symptom 1177 1179	S3
E35	Sign_symptom:T54 
#1	AnnotatorNotes E35	specifically, S3 heart sound
T55	Sign_symptom 1181 1196	pulmonary rales
E36	Sign_symptom:T55 
T56	Sign_symptom 1219 1224	edema
E37	Sign_symptom:T56 
T57	Detailed_description 1208 1218	peripheral
T58	Severity 1202 1207	trace
R15	MODIFY Arg1:T57 Arg2:E37	
R16	MODIFY Arg1:T58 Arg2:E37	
T59	Diagnostic_procedure 1234 1251	laboratory values
E38	Diagnostic_procedure:T59 
R17	MODIFY Arg1:T53 Arg2:E34	
T60	Lab_value 1257 1277	within normal limits
R18	MODIFY Arg1:T60 Arg2:E38	
T61	Diagnostic_procedure 1310 1350	N-terminal pro-brain natriuretic peptide
E39	Diagnostic_procedure:T61 
T62	Lab_value 1352 1364	>2,000 pg/mL
R19	MODIFY Arg1:T62 Arg2:E39	
T63	Lab_value 1292 1300	elevated
R20	MODIFY Arg1:T63 Arg2:E39	
T64	Disease_disorder 1411 1425	cardiomyopathy
E40	Disease_disorder:T64 
T65	Diagnostic_procedure 1442 1456	cardiac enzyme
E41	Diagnostic_procedure:T65 
T66	Lab_value 1435 1441	normal
R21	MODIFY Arg1:T66 Arg2:E41	
T67	Diagnostic_procedure 1468 1485	electrocardiogram
E42	Diagnostic_procedure:T67 
T68	Diagnostic_procedure 1487 1490	ECG
E43	Diagnostic_procedure:T68 
R22	IDENTICAL Arg1:E43 Arg2:E42	
T69	Sign_symptom 1509 1525	ischemic changes
E44	Sign_symptom:T69 
A2	POLARITY E44 NEG
T70	Diagnostic_procedure 1542 1551	angiogram
E45	Diagnostic_procedure:T70 
T71	Biological_structure 1533 1541	coronary
R23	MODIFY Arg1:T71 Arg2:E45	
T72	Lab_value 1555 1561	normal
R24	MODIFY Arg1:T72 Arg2:E45	
T73	Diagnostic_procedure 1578 1581	ECG
E46	Diagnostic_procedure:T73 
T74	Sign_symptom 1595 1606	tachycardia
E47	Sign_symptom:T74 
T75	Detailed_description 1589 1594	sinus
R25	MODIFY Arg1:T75 Arg2:E47	
T76	Sign_symptom 1654 1673	left-axis deviation
E48	Sign_symptom:T76 
T77	Sign_symptom 1621 1652	premature ventricular complexes
E49	Sign_symptom:T77 
T78	Frequency 1612 1620	frequent
R26	MODIFY Arg1:T78 Arg2:E49	
T79	Sign_symptom 1687 1698	enlargement
E50	Sign_symptom:T79 
T80	Biological_structure 1675 1686	left atrial
R27	MODIFY Arg1:T80 Arg2:E50	
T81	Sign_symptom 1716 1729	QRS complexes
E51	Sign_symptom:T81 
T82	Detailed_description 1704 1715	low-voltage
R28	MODIFY Arg1:T82 Arg2:E51	
T83	Sign_symptom 1747 1757	ST changes
E52	Sign_symptom:T83 
T84	Detailed_description 1735 1746	nonspecific
R29	MODIFY Arg1:T84 Arg2:E52	
T85	Diagnostic_procedure 1783 1797	echocardiogram
E53	Diagnostic_procedure:T85 
T86	Detailed_description 1769 1782	2-dimensional
R30	MODIFY Arg1:T86 Arg2:E53	
T87	Diagnostic_procedure 1809 1843	left ventricular ejection fraction
E54	Diagnostic_procedure:T87 
T88	Diagnostic_procedure 1845 1849	LVEF
E55	Diagnostic_procedure:T88 
R31	IDENTICAL Arg1:E55 Arg2:E54	
T89	Lab_value 1854 1858	0.20
R32	MODIFY Arg1:T89 Arg2:E54	
T90	Sign_symptom 1897 1908	hypokinesis
E56	Sign_symptom:T90 
T91	Sign_symptom 1923 1930	dilated
E57	Sign_symptom:T91 
T92	Severity 1860 1866	severe
T93	Biological_structure 1875 1891	left ventricular
T94	Detailed_description 1867 1874	diffuse
T95	Biological_structure 1893 1895	LV
R33	IDENTICAL Arg1:T95 Arg2:T93	
R34	MODIFY Arg1:T93 Arg2:E56	
R35	MODIFY Arg1:T94 Arg2:E56	
R36	MODIFY Arg1:T92 Arg2:E56	
T96	Severity 1916 1922	mildly
R37	MODIFY Arg1:T96 Arg2:E57	
T97	Biological_structure 1931 1942	left atrium
R38	MODIFY Arg1:T97 Arg2:E57	
T98	Diagnostic_procedure 2003 2036	cardiovascular magnetic resonance
E58	Diagnostic_procedure:T98 
T99	Diagnostic_procedure 2038 2041	CMR
E59	Diagnostic_procedure:T99 
R39	IDENTICAL Arg1:E59 Arg2:E58	
T100	Diagnostic_procedure 2075 2079	LVEF
E60	Diagnostic_procedure:T100 
T101	Lab_value 2083 2087	0.20
R40	MODIFY Arg1:T101 Arg2:E60	
T103	Diagnostic_procedure 2093 2113	T2-weighted sequence
E62	Diagnostic_procedure:T103 
R41	SUB_PROCEDURE Arg1:E62 Arg2:E58	
T102	Disease_disorder 2147 2158	dysfunction
E61	Disease_disorder:T102 
T104	Diagnostic_procedure 2126 2130	flow
E63	Diagnostic_procedure:T104 
T105	Lab_value 2121 2125	slow
R42	MODIFY Arg1:T105 Arg2:E63	
T106	Biological_structure 2144 2146	LV
R43	MODIFY Arg1:T106 Arg2:E61	
T107	Sign_symptom 2178 2183	edema
E64	Sign_symptom:T107 
A3	POLARITY E64 NEG
T108	Biological_structure 2167 2177	myocardial
R44	MODIFY Arg1:T108 Arg2:E64	
T109	Diagnostic_procedure 2199 2221	gadolinium enhancement
E65	Diagnostic_procedure:T109 
R45	SUB_PROCEDURE Arg1:E65 Arg2:E58	
T110	Detailed_description 2194 2198	Late
R46	MODIFY Arg1:T110 Arg2:E65	
T111	Sign_symptom 2251 2259	thinning
E66	Sign_symptom:T111 
T112	Biological_structure 2240 2250	myocardial
R47	MODIFY Arg1:T112 Arg2:E66	
T113	Detailed_description 2232 2239	diffuse
R48	MODIFY Arg1:T113 Arg2:E66	
T114	Therapeutic_procedure 2302 2319	treated medically
E67	Therapeutic_procedure:T114 
T115	Sign_symptom 2325 2333	symptoms
E68	Sign_symptom:T115 
A4	TREND E68 DEC
T116	Lab_value 2348 2356	improved
R49	MODIFY Arg1:T116 Arg2:E68	
T117	Therapeutic_procedure 2364 2371	therapy
E69	Therapeutic_procedure:T117 
T118	Medication 2394 2403	Î²-blocker
E70	Medication:T118 
T119	Medication 2408 2447	angiotensin-converting enzyme inhibitor
E71	Medication:T119 
T120	Medication 2449 2456	digoxin
E72	Medication:T120 
T121	Medication 2464 2472	diuretic
E73	Medication:T121 
T122	Coreference 2478 2485	therapy
E74	Coreference:T122 
A5	TREND E74 DEC
R50	IDENTICAL Arg1:E74 Arg2:E69	
T123	Lab_value 2497 2504	tapered
R51	MODIFY Arg1:T123 Arg2:E74	
T124	Diagnostic_procedure 2514 2518	LVEF
E75	Diagnostic_procedure:T124 
T125	Lab_value 2519 2528	increased
R52	MODIFY Arg1:T125 Arg2:E75	
T126	Lab_value 2534 2538	0.20
T127	Lab_value 2542 2546	0.55
T128	Duration 2557 2571	8-month period
E76	Duration:T128 
R53	MODIFY Arg1:T126 Arg2:E75	
R54	MODIFY Arg1:T127 Arg2:E75	
T129	Medication 2577 2588	medications
E77	Medication:T129 
A6	POLARITY E77 NEG
T130	Lab_value 2625 2637	discontinued
R55	MODIFY Arg1:T130 Arg2:E77	
T131	Medication 2609 2619	metoprolol
E78	Medication:T131 
T132	Dosage 2600 2608	low-dose
R56	MODIFY Arg1:T132 Arg2:E78	
T133	Date 2638 2650	after 1 year
E79	Date:T133 
T134	Sign_symptom 2669 2681	asymptomatic
E80	Sign_symptom:T134 
T135	Detailed_description 63 68	acute
R57	MODIFY Arg1:T135 Arg2:E3	
*	OVERLAP E2 E3 E1
R58	AFTER Arg1:E3 Arg2:E4	
*	OVERLAP E4 E5 E6 E7 E8
R59	AFTER Arg1:E8 Arg2:E9	
*	OVERLAP E9 E10 E11
R60	BEFORE Arg1:E11 Arg2:E12	
*	OVERLAP E12 E13
R61	BEFORE Arg1:E13 Arg2:E14	
R62	MODIFY Arg1:T30 Arg2:E15	
R63	MODIFY Arg1:T30 Arg2:E16	
R64	MODIFY Arg1:T30 Arg2:E17	
*	OVERLAP E14 E15 E16 E17
R65	BEFORE Arg1:E17 Arg2:E18	
*	OVERLAP E18 E19 E20
R66	BEFORE Arg1:E20 Arg2:E21	
*	OVERLAP E21 E22 E23
R67	BEFORE Arg1:E23 Arg2:E24	
R68	BEFORE Arg1:E24 Arg2:E25	
*	OVERLAP E25 E26
R69	BEFORE Arg1:E26 Arg2:E27	
R70	BEFORE Arg1:E27 Arg2:E28	
*	OVERLAP E28 E29 E30
R71	BEFORE Arg1:E30 Arg2:E31	
*	OVERLAP E31 E32 E33 E34 E35 E36 E37 E38 E39 E40 E41 E42 E44 E45 E46 E47 E49 E48 E50 E51 E52 E53 E54 E56 E57 E58 E60 E63 E61 E64 E66 E81
T136	Sign_symptom 2267 2275	scarring
E81	Sign_symptom:T136 
A7	POLARITY E81 NEG
R72	BEFORE Arg1:E81 Arg2:E67	
*	OVERLAP E67 E68 E69
R73	SUB_PROCEDURE Arg1:E70 Arg2:E69	
R74	SUB_PROCEDURE Arg1:E71 Arg2:E69	
R75	SUB_PROCEDURE Arg1:E72 Arg2:E69	
R76	SUB_PROCEDURE Arg1:E73 Arg2:E69	
R77	BEFORE Arg1:E69 Arg2:E74	
*	OVERLAP E74 E75 E76
R78	BEFORE Arg1:E76 Arg2:E77	
*	OVERLAP E77 E78 E79 E80
